As far as molecular genetics is concerned, ACP is characterized by mutations that activate Wnt pathway gene CTNNB1 encoding β-catenin in most of the cases, while PCP is characterized by BRAF V600E mutation in more than 90% of cases [1,2,6]. The gene discussed is BRAF; the disease is pneumocystosis.